<p>Cue-induced drug seeking (cues present but no drug infusions;1 h) after an abstinence period of 6 weeks with comparison between offspring groups (placebo, naltrexone). A: Cumulative response record for cue-induce drug-seeking divided into 10 minute time bins. Data are expressed as number of active lever presses and represent mean ± SEM (two-way ANOVA, * <i>p</i><0.05, naltrexone (n = 9) versus placebo (n = 7) for each time bin). B: Total active and inactive lever presses during the drug-seeking session (represented by white bars, placebo: n = 9, naltrexone: n = 7) as compared to lever presses during 7 days of stable responding under a fixed-ratio 1 (represented by black bars, placebo: n = 12, naltrexone: n = 9). Data expressed as number ...
The non-selective opioid receptor antagonist naltrexone reduces cocaine-induced reinstatement of dru...
Background: Naltrexone (NTX) has proven to be effective with alcoholics in treatment, with most cont...
<p><i>Background</i>: ALO-02, comprising pellets of extended-release oxycodone surrounding sequester...
<p>Morphine self-administration under a fixed-ratio of 1 lever press and acquisition of a stable res...
<p>Morphine self-administration under a progressive ratio (PR) schedule of 3–4 (see <a href="http://...
<p>Locomotor activity is shown on days 1–3, after saline or morphine administration on days 4–8 (10 ...
Methamphetamine (MA) use disorder is a serious psychiatric condition for which there are no FDA-appr...
Methamphetamine (MA) use disorder is a serious psychiatric condition for which there are no FDA-appr...
Reductions in cue-induced craving and subjective response to drugs of abuse are commonly used as ini...
<p><b>A:</b> Experimental procedure of naloxone-precipitated withdrawal-induced CPA. The preference ...
The ability of alcohol-related cues to promote craving can be attenuated independently by giving the...
Relapse to alcohol addiction after prolonged withdrawal periods is a major problem in the treatment ...
Naltrexone is an opioid receptor antagonist used in the management of alcohol dependence. Although t...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66264/1/j.1530-0277.1999.tb04173.x.pd
During the first weeks of abstinence, alcohol craving in patients may increase or “incubate.” We hyp...
The non-selective opioid receptor antagonist naltrexone reduces cocaine-induced reinstatement of dru...
Background: Naltrexone (NTX) has proven to be effective with alcoholics in treatment, with most cont...
<p><i>Background</i>: ALO-02, comprising pellets of extended-release oxycodone surrounding sequester...
<p>Morphine self-administration under a fixed-ratio of 1 lever press and acquisition of a stable res...
<p>Morphine self-administration under a progressive ratio (PR) schedule of 3–4 (see <a href="http://...
<p>Locomotor activity is shown on days 1–3, after saline or morphine administration on days 4–8 (10 ...
Methamphetamine (MA) use disorder is a serious psychiatric condition for which there are no FDA-appr...
Methamphetamine (MA) use disorder is a serious psychiatric condition for which there are no FDA-appr...
Reductions in cue-induced craving and subjective response to drugs of abuse are commonly used as ini...
<p><b>A:</b> Experimental procedure of naloxone-precipitated withdrawal-induced CPA. The preference ...
The ability of alcohol-related cues to promote craving can be attenuated independently by giving the...
Relapse to alcohol addiction after prolonged withdrawal periods is a major problem in the treatment ...
Naltrexone is an opioid receptor antagonist used in the management of alcohol dependence. Although t...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66264/1/j.1530-0277.1999.tb04173.x.pd
During the first weeks of abstinence, alcohol craving in patients may increase or “incubate.” We hyp...
The non-selective opioid receptor antagonist naltrexone reduces cocaine-induced reinstatement of dru...
Background: Naltrexone (NTX) has proven to be effective with alcoholics in treatment, with most cont...
<p><i>Background</i>: ALO-02, comprising pellets of extended-release oxycodone surrounding sequester...